NO170282C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater

Info

Publication number
NO170282C
NO170282C NO892772A NO892772A NO170282C NO 170282 C NO170282 C NO 170282C NO 892772 A NO892772 A NO 892772A NO 892772 A NO892772 A NO 892772A NO 170282 C NO170282 C NO 170282C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogy procedure
diazepine derivatives
diazepine
Prior art date
Application number
NO892772A
Other languages
English (en)
Norwegian (no)
Other versions
NO892772L (no
NO170282B (no
NO892772D0 (no
Inventor
Jacobus Antonius Jeseph Hartog
Herman Heinrich Va Stuivenberg
Ineke Van Wijngaarden
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of NO892772D0 publication Critical patent/NO892772D0/no
Publication of NO892772L publication Critical patent/NO892772L/no
Publication of NO170282B publication Critical patent/NO170282B/no
Publication of NO170282C publication Critical patent/NO170282C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO892772A 1988-07-07 1989-07-04 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater NO170282C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8801716 1988-07-07

Publications (4)

Publication Number Publication Date
NO892772D0 NO892772D0 (no) 1989-07-04
NO892772L NO892772L (no) 1990-01-08
NO170282B NO170282B (no) 1992-06-22
NO170282C true NO170282C (no) 1992-09-30

Family

ID=19852585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892772A NO170282C (no) 1988-07-07 1989-07-04 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater

Country Status (16)

Country Link
US (2) US4985423A (ja)
EP (1) EP0350131A3 (ja)
JP (1) JPH0259582A (ja)
KR (1) KR900001696A (ja)
CN (1) CN1028408C (ja)
AU (1) AU626892B2 (ja)
CA (1) CA1315781C (ja)
DK (1) DK330689A (ja)
FI (1) FI93118C (ja)
HU (1) HU204528B (ja)
IL (1) IL90865A (ja)
NO (1) NO170282C (ja)
NZ (1) NZ229815A (ja)
PT (1) PT91052B (ja)
TW (1) TW219896B (ja)
ZA (1) ZA895086B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015904D0 (en) 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
DE10312969A1 (de) * 2003-03-24 2004-10-07 Bayer Healthcare Ag Benzofuro-1,4-diazepin-2-on-Derivate
WO2009049362A1 (en) * 2007-10-15 2009-04-23 Monash University A1 adenosine receptor allosteric enhancers
WO2015088565A1 (en) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910887A (en) * 1972-12-07 1975-10-07 Degussa Azabenzo-1,5-diazepines
US4404137A (en) * 1979-10-16 1983-09-13 Lilly Industries Limited Pyrazolo [3,4-b][1,5]benzodiazepine compounds
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
US5087625A (en) * 1990-10-19 1992-02-11 Boehringer Ingelheim Pharmaceuticals, Inc. Pyridodiazepines and their use in the prevention or treatment of HIV infection

Also Published As

Publication number Publication date
FI893250A (fi) 1990-01-08
FI893250A0 (fi) 1989-07-04
PT91052B (pt) 1995-01-31
US4985423A (en) 1991-01-15
NO892772L (no) 1990-01-08
TW219896B (ja) 1994-02-01
EP0350131A3 (en) 1991-07-10
FI93118B (fi) 1994-11-15
NZ229815A (en) 1992-03-26
EP0350131A2 (en) 1990-01-10
DK330689A (da) 1990-01-08
IL90865A (en) 1994-02-27
PT91052A (pt) 1990-02-08
AU626892B2 (en) 1992-08-13
KR900001696A (ko) 1990-02-27
US5140024A (en) 1992-08-18
CN1028408C (zh) 1995-05-17
AU3795489A (en) 1990-01-11
DK330689D0 (da) 1989-07-04
CN1040027A (zh) 1990-02-28
FI93118C (fi) 1995-02-27
NO170282B (no) 1992-06-22
CA1315781C (en) 1993-04-06
HU204528B (en) 1992-01-28
NO892772D0 (no) 1989-07-04
ZA895086B (en) 1990-05-30
JPH0259582A (ja) 1990-02-28
IL90865A0 (en) 1990-02-09

Similar Documents

Publication Publication Date Title
NO171272C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO895086L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO172539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO171847C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO170282C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater
NO162468C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino (4[,5[;3,4)-pyrrolo-( 2,1-a)-isokinolinderivater.